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ABSTRACT
Objective: Prolonged and persistent hyperglycemia in diabetes mellitus (DM) leads to a variety of vascular complications, including the retinal disorder 
of diabetic retinopathy (DR). The mechanism of fructose formation of sorbitol assisted by sorbitol dehydrogenase (SDH) causing the loss of pericytes 
in the blood vessel is affected by epigenetic work comprised of deoxyribonucleic acid (DNA) methylation, histone acetylation, and microRNA‑320. This 
study aimed to determine the correlation of DNA methylation, histone acetylation, and microRNA‑320 with SDH in DR.
Methods: This case–control study was conducted at a tertiary general hospital from July 2014 to June 2016. Study subjects were type 2 DM patients 
with and without DR, over 40 years old, suffered from DM for > 10 years. DNA methylation, histone acetylation, and microRNA‑320 were examined 
by real‑time quantitative polymerase chain reaction, while SDH level examination was carried out by enzyme‑linked immunosorbent assay. Analyses 
were performed with independent t‑test, Mann–Whitney, Spearman correlation, and multiple linear regression.
Results: With respect to SDH, DNA methylation showed no significant correlation so as histone acetylation, in contrary to microRNA‑320 with a very 
strong negative correlation (r=−0.968, P < 0.005).
Conclusion: MicroRNA‑320 was correlated to SDH in a manner of protective properties against the occurrence of DR. Involvement of DNA methylation 
and histone acetylation was perceptible in influencing SDH enzyme despite their insignificance if they took place individually.
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INTRODUCTION
Diabetes mellitus (DM) is a chronic disease characterized by an 
elevated plasma glucose level or hyperglycemia due to impaired 
insulin secretion and/or insulin resistance. Prolonged and persistent 
hyperglycemia in DM leads to a variety of vascular complications, in 
which one of the microvascular complications is a major cause of vision 
problems worldwide, diabetic retinopathy (DR) [1‑3]. The number 
of DM sufferers worldwide in 2000 was around 171 million, and it is 
estimated that, by 2030, it will reach 366 million. Complication of DM 
aside from blindness is increased overall health financing. In United 
States (US), the cost for the treatment and prevention of DM and its 
complications is estimated to reach US$490 billion in 2030 [1,4,5].
Retinal vascular disorders occur as a result of hyperglycemia through 
the pathways of polyols, protein kinase C (PKC), advanced glycation end 
products (AGEs), hexosamine, and oxidative stress. Excessive reactive 
oxygen species (ROS) causes reduced pericytes, microaneurysms, 
exudates, edema, and bleeding around the retina, eventually leading to 
blindness [6‑8]. In addition to the loss of pericytes, there is also another 
role for ROS to damage retinal endothelial cells. Damage to retinal 
endothelial cells is also exacerbated by an increase in AGEs production 
due to hyperglycemia [6,9].
Blindness is not only related to the role of sorbitol dehydrogenase (SDH) 
and nicotinamide adenine dinucleotide phosphate co‑factor but also 
other factors such as genetic or epigenetic. Genetics influence the level 
of methylation of deoxyribonucleic acid (DNA), acetylation of histones, 
and ribonucleic acid (RNA). Examination is suggested on the role of 
DNA methylation, histone acetylation, and microRNA‑320 with SDH 
enzyme in type 2 DM patients with a complication of retinopathy as 
an early detection of DR to prevent permanent blindness. This study 
aimed to determine the correlation between DNA methylation, histone 
acetylation, and microRNA‑320 with SDH in DR.
METHODS
This case–control study was carried out in the Eye Polyclinic of 
Vitreoretina, Mohammad Hoesin General Hospital, Palembang, 
Indonesia, from July 2014 to June 2016. Consents from participants 
were legitimated by signing an informed consent. This study obtained 
ethical approval from the health research ethics committee (094/UN6.
C1.3.2/KEPK/PN/2015). DM was defined as a condition with fasting 
plasma glucose level of > 120 mg/dl and postprandial of > 200 mg/dl 
and had endured from DM for > 5 year. Ophthalmoscopy findings (Neitz 
Instruments Co., Ltd., Japan) of microaneurysms, exudates, bleeding, 
and neovascularization were defined as DR.
Patients’ eligibility
The study subjects were DR patients at an Eye Polyclinic of Vitreoretina 
Subdivision, aged over 40 years, who had experienced DM for > 10 years, 
as cases. Age‑ and gender‑matched DM patients without non‑DR (NDR) 
were selected as controls. Patients with leukemia retinopathy, retinitis 
pigmentosa, and chorioretinitis were excluded from the study.
Blood specimen preparation
As many as 5 ml of venous blood specimens was withdrawn and put into 
ethylenediaminetetraacetic acid (EDTA) tubes for DNA and RNA isolation 
and non‑EDTA tubes for SDH enzyme‑linked immunosorbent assay (ELISA).
DNA methylation (Abcam plc., Cambridge, UK), histone acetylation (Abcam 
plc., Cambridge, UK), and microRNA‑320 were examined by real‑time 
quantitative polymerase chain reaction (RT‑qPCR) (Bio‑Rad Laboratories, 
Inc., California, USA), while SDH level examination (Cloud‑Clone Corp., 
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Texas, USA) was carried out by ELISA (Bio‑Rad Laboratories, Inc., 
California, USA).
DNA methylation examination
A single point control was made by diluting the positive control. The 
addition of 80 µl binding solution and 1 µl DNA sample at each well 
was performed before incubation for 90 min at 37°C, followed by 
washing and addition procedures for 50 µl of capture antibody, 50 µl 
detection antibody, and 50 µl of diluted solution enhancer. Methylated 
DNA observation was carried out by the addition of 100 µl developer 
solution. Sufficient methylated DNA was marked by blue color alteration. 
The color turned yellow after the addition of 50 µl of stop solution and 
absorbance was examined on the microplate reader at 450 nm.
Histone acetylation examination
Histone extraction was performed starting from the addition of 10 µl 
lysis buffer and 300 µl extraction buffer in 100 µl blood samples. After 
12,000 rpm centrifugation for 5 min at 4°C, the supernatant was taken 
and followed by the addition of trichloracetic acid 100% with a ratio of 
1:4, followed by washing with 1 ml acetone, then centrifuged at 1200 rpm 
for 2 min at 4°C. The supernatant was then discarded to obtain pellets, 
and the pellets were dissolved with 10 µl of distilled water. Each sample 
was processed with 5 µl histone buffer, 150 µl blocking buffer, and 50 µl 
diluted captured antibody. Readings at a wavelength of 450 nm were 
carried out after the samples were processed with developing solution 
and stop solution.
MicroRNA‑320 examination
RNA isolation was performed before complementary DNA (cDNA) 
synthesis with 2 µl × 5 reaction buffer, 4.5 µl nuclease free water, 
1 µl enzyme mix, 0.5 µl RNAse, and 2 µl RNA sample. Incubation for 
60 min was carried out at 42°C and then for 5 min at 95°C followed by 
storing in the refrigerator at 4°C. Dilution of cDNA was performed with 
nuclease‑free water with a ratio of 1:80. RT‑qPCR was performed.
SDH examination
SDH examination was initiated with the preparation of standards with 
standard solutions and standard dilution buffers. After the samples were 
transferred into each well, incubation was carried out for 30 min at 37°C, 
followed by dilution of the washing buffer and washing procedures. 
Horseradish peroxidase conjugate reagent of 50 µl was added, followed 
by staining with 50 µl of chromogen solution A and 50 µl of chromogen 
solution B, and terminated with 50 µl stop solution. Color alteration of blue to 
yellow was observed. Absorbance was read on a microplate reader at 450 nm.
Data analysis
Before statistical tests on numerical data, normality tests were assessed 
using Kolmogorov–Smirnov. To compare the two groups in a numerical 
scale, independent t‑test was used for normally distributed data and 
otherwise with Mann–Whitney. Analysis for the correlation between 
variables was performed with Spearman correlation. Interpretation 
of the results was based on correlation strength, direction, and level 
of significance. Correlation strength (r) was based on Guillford (1956) 
criteria. The significance level was P < 0.05. The data obtained 
were recorded in a form and processed with SPSS 21.0 (SPSS Inc., 
Chicago, USA).
RESULTS
The study subjects were comprised of 40 DR and 40 NDR patients 
obtained consecutively. There were no significant differences present on 
age, gender, and blood pressure between DR and NDR groups as shown 
in Table 1. Nevertheless, the DR group exhibited slight older mean of age 
and larger number of participant with normal blood pressure (systolic 
blood pressure < 140 mmHg and diastolic < 90 mmHg) compared to 
NDR. Both groups of DR and NDR consisted of the same number of 
male and female participants. There were no significant differences in 
DNA methylation and histone acetylation between DR and NDR groups. 
Nevertheless, DR group exhibited lower DNA methylation and higher 
histone acetylation, whereas, for microRNA‑320 and SDH, significant 
differences were observed between DR and NDR groups. MicroRNA‑320 
copy for DR was found to be lower compared to NDR group. DR group 
exhibited higher SDH level compared to NDR.
In bivariate analysis, with respect to SDH of DR patients, there was a 
very weak positive relationship with DNA methylation and a very weak 
negative correlation with histone acetylation as shown in Table 2. 
There was a significant very strong negative correlation between 
microRNA‑320 and SDH of DR patients, where the lower microRNA‑320 
provoked higher SDH and vice versa. Based on multivariate analysis 
as shown in Table 2, with respect to SDH of DR patients, there was a 
very weak positive correlation with DNA methylation and histone 
acetylation. However, there was a significant strong negative correlation 
between microRNA‑320 and SDH of DR patients.
DISCUSSION
In this study, the incidence of DR was at mean age of 56.88 ± 6.35 years 
and the NDR group 54.30 ± 4.83 years. Other studies discovered the 
average age affected by DR which was between 40 and 65 years [10]. 
In a multicenter study in Mexican‑American, it was found that the 
average age of 60–69 years suffered more from DR [2,3]. Of all type 2 
DM patients, 23% suffers from non‑proliferative DR after 5–13 years, 
41% after 14–16 years, and 60% after 16 year [4,7,11‑13].
In the gender of DR and NDR participants in this study, female 
dominated over male in number. Similar to a multicenter study in 
Mexican‑American, those affected by DR were 37.3% of men and 
62.7% of women [2,3]. On subjects with the age as in this study, high 
Table 1: Baseline characteristics
Characteristics Diabetic retinopathy (DR) (n=40) Non‑diabetic retinopathy (DR) (n=40) p‑value
Age (year) 
Mean±SD 56.88±6.35 54.3±4.83 0.140a
Gender
Male n(%) 11/40 (27.5) 11/40 (27.5) 1.000b
Female n(%) 29/40 (72.5) 29/40 (72.5)
Blood pressure
Normal n (%) 29/40 (72.5) 26/40 (65.0) 0.630b
High n (%) 11/40 (27.5) 14/40 (35.0)
DNA methylation (%)
Median (min–max) 19.9 (11.2–126.37) 29.5 (10.1–82.13) 0.256a
Histone acetylation (%)
Median (min–max) 9.29 (5.61–25.27) 7.99 (6.69–29.69) 0.758a
MicroRNA‑320 (copy)
Mean±SD 11.74±1.04 12.29±0.81 0.010b*
SDH (pg/ml)
Median (min–max) 11.69 (6.16–54.60) 10.78 (6.55–15.69) 0.044a*
SD: Standard deviation, n: Number, DNA: Deoxyribonucleic acid, RNA: Ribonucleic acid, aMann–Whitney, bIndependent t‑test, *p<0.05, SDH: Sorbitol dehydrogenase
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possibility of female participants entering menopause was observed 
with hormonal factors aggravated the onset of retinopathy [14].
Less DR occurred at younger age without hypertension as observed 
in this study. The occurrence of DR depends on retinal blood vessel 
abnormalities. Pathogenesis of hypertensive retinopathy and DR is 
distinct. One is the damage due to peripheral vascular pressure and 
the other is the damage to the endothelial wall and pericyte. A study 
discovered that any reduction in systolic blood pressure by 10 mmHg 
was equivalent to a reduced risk of retinopathy by 40% [7,11‑13].
The mean of DNA methylation in DR group was lower compared to 
NDR. It was assumed that there was an inhibition of DNA methylation 
so that gene expression increased to form an enzyme, in this case, SDH. 
DNA methylation affects gene transcription in two ways. First, DNA 
methylation itself physically inhibits the binding of transcriptional 
proteins to genes. Second and perhaps more importantly, methylated 
DNA is bound by proteins known as methyl‑CpG binding proteins. 
This protein then recruits additional proteins to the locus, such as 
histone deacetylase and other remodeling protein chromatin which can 
modify histones, thus forming inactive and less accessible chromatin 
for transcription processes [15,16]. The binding proteins also form 
complexes with proteins involved in histone deacetylation. Therefore, 
when DNA is methylated, the nearby histones will be acetylated and 
produced a compound inhibitory effect on transcription. Likewise, 
demethylated DNA does not attract deacetylation enzymes to the 
histones, thus allowing them to remain mobile and encouraging 
transcription [17,18].
On histone acetylation examination, the mean histone acetylation in 
DR group was greater compared to NDR. In another study of in vitro 
and in vivo, increased histone deacetylation and decreased histone 
acetyltransferase were exhibited, which participated in acetylation 
of the retina and capillary cells. Contrary to this, Kadiyala et al. as 
quoted in Kowluru et al. showed an increase in histone acetylation in 
diabetes [14]. Histone itself is divided into four, where the one used 
in this study was histone acetylation of H3. The results obtained 
histone acetylation of DR group was of higher value, although it was 
not statistically significant. It was assumed that there was another 
histone role that affected this histone acetylation. One of them was 
histone methylation, in a contrary manner, as a factor of repression. 
Several other factors were assumed to likely influence the results of 
H3 acetylation in this study. Examining other histones might better 
illustrate the pattern of this histone work.
Another epigenetic work examined was microRNA. In this study, 
microRNA‑320 was used specifically for SDH enzymes. In microRNA‑320 
examination, the mean of DR group was lower compared to NDR. In the 
analysis, it was assumed that microRNA was a protective factor. This 
was interpreted that the greater level of microRNA provoked greater 
protective properties against the occurrence of DR. MicroRNA‑320 
possesses a broad range of biological effects because it regulates 
several important molecules. The main targets include expression of 
endothelin (ET‑1), extracellular signal‑regulated kinase1, vascular 
endothelial growth factor (VEGF), and fibronectin. Its biological 
actions include the effects on carcinogenesis, development, and 
reperfusion injury for ischemia. MicroRNA‑320 expression increases 
and consequently a decrease in insulin‑like growth factor 1 (IGF‑1) 
and IGF‑1R expression tends to play a role in angiogenesis disorders 
observed in diabetes [19].
In this study, SDH level in DR group was higher compared to NDR. DR was 
associated with altered retinal configuration as observed in the NH‑OH, CH, 
and fingerprint regions in Fourier‑transform infrared spectroscopy 
bands [20]. Damages or apoptosis in retinal cells is caused by elevated 
osmotic activity in the retina. This osmotic increase is caused by the role of 
the polyol pathway. In polyol pathway, aldose reductase (ALR) is the initial 
enzyme catalyzing the conversion of glucose to sorbitol, followed by the 
conversion of sorbitol to fructose by SDH. The sorbitol attenuates cellular 
homeostasis, followed by oxidative damage causing reduced pericytes, 
microaneurysms, exudates, edema, and bleeding around the retina [6‑8]. 
A study by Dongare et al. exhibited that ALR and VEGF‑165 messenger 
RNA (mRNA) expression analyzed by RT‑PCR were increased with high 
concentration of glucose [21]. In another study, Preston et al. obtained that 
serum levels of sorbitol were elevated after meal, in accordance with the 
mechanism of hyperglycemia [22]. Higher SDH enzyme level in DR group 
of this study exhibited an increase in gene expression of SDH enzyme in 
the DR group, eventually leading to retinal vascular damage.
In multivariate analysis of this study, a correlation between 
microRNA‑320 and SDH was observed. Although, in this multivariate 
analysis, histone acetylation and DNA methylation did not possess 
significant roles in elevating SDH enzyme, their interaction with 
microRNA‑320 would still lead to DR. DNA methylation, histone 
acetylation, and micro‑320 RNA are non‑coding factors that contribute 
to DR so that prevention of DR can be exerted by examining these factors. 
Further study on epigenetic factors such as histone phosphorylation 
and methylation, HbA1C, lipid levels, ROS, AGEs, and PKC are suggested 
to dissect risk factors of DR.
Limitations of this study comprised the uncollected data on subjects 
such as glycemic control, HbA1C, and the types of drugs used. This might 
contribute to differences in this study results. Another was the need for 
a third comparison in this case the population without diabetes to yield 
better analysis. The pathogenesis of DR was broadly complex, so this study 
required other epigenetic examinations such as histone methylation and 
histone phosphorylation. In addition, examinations of other enzymes 
simultaneously such as AGEs, PKC, and ROS were to obtain more accurate 
results. Because the processes in DR were multi‑factorial, further studies 
are in necessity to obtain exact patterns in DR pathogenesis.
CONCLUSION
MicroRNA‑320 was correlated to SDH in a manner of protective 
properties against the occurrence of DR. Involvement of DNA 
methylation and histone acetylation were perceptible in influencing 
SDH enzyme despite their insignificance if they took place individually.
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